Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
MDMA
Biotech
After FDA rejection and layoffs, Lykos' CEO is leaving
Lykos CEO Amy Emerson is stepping down, with Chief Operating Officer Michael Mullette taking over the top spot on an interim basis.
Gabrielle Masson
Sep 5, 2024 1:39pm
PharmAla launches tool aimed at easing access to MDMA drug info
Aug 28, 2024 12:55pm
Lykos caps off chaotic week by cutting 75% of staff
Aug 15, 2024 3:59pm
Lykos 'regrets' not disclosing study violations with publisher
Aug 12, 2024 3:39pm
Lykos' MDMA treatment for PTSD has been quashed at the FDA
Aug 10, 2024 9:07am
With MDMA debate spreading, Lykos CEO tries to dispel concerns
Jun 13, 2024 10:22am